Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int Immunopharmacol ; 99: 108000, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34352566

RESUMEN

Mesenchymal stem cells (MSCs), due to their multi-directional differentiation, paracrine and immunomodulation potentials, and the capacity of homing to target organ, have been reported to facilitate regeneration and repair of kidney and improve kidney function in acute or chronic kidney injury. The present study was aimed to evaluate whether MSCs could have a protective effect in hyperuricemic nephropathy (HN) and the underlying mechanisms. A rat HN model was established by oral administration of a mixture of potassium oxonate (PO, 1.5 g/kg) and adenine (Ad, 50 mg/kg) daily for 4 weeks. For MSCs treatment, MSCs (3 × 106 cells/kg per week) were injected via tail vein from the 2nd week for 3 times. The results showed that along with the elevated uric acid (UA) in HN rats, creatinine (CREA), blood urea nitrogen (BUN), microalbuminuria (MAU) and 24-hour urinary protein levels were significantly increased comparing with the normal control rats, while decreased after MSCs treatment. Moreover, the mRNA levels of inflammation and fibrosis-related gene were reduced in UA + MSCs group. Consistently, hematoxylin-eosin (HE) staining results showed the destruction of kidney structure and fibrosis were significantly alleviated after MSCs administration. Similarly, in vitro, NRK-52Es cells were treated with high concentration UA (10 mg/dL) in the presence of MSCs, and we found that MSCs co-culture could inhibited UA-induced cell injury, characterized as improvement of cell viability and proliferation, inhibition of apoptosis, inflammation, and fibrosis. Collectively, MSCs treatment could effectively attenuate UA-induced renal injury, and thus it might be a potential therapy to hyperuricemia-related renal diseases.


Asunto(s)
Hiperuricemia/metabolismo , Células Madre Mesenquimatosas/metabolismo , Ácido Úrico/metabolismo , Animales , Proteínas Reguladoras de la Apoptosis/metabolismo , Técnicas de Cultivo de Célula , Supervivencia Celular , Fibrosis , Hiperuricemia/sangre , Hiperuricemia/inducido químicamente , Inflamación , Riñón/patología , Masculino , Trasplante de Células Madre Mesenquimatosas , Ratas , Ratas Sprague-Dawley , Ácido Úrico/sangre , Ácido Úrico/toxicidad
3.
Zhongguo Zhen Jiu ; 26(8): 605-8, 2006 Aug.
Artículo en Chino | MEDLINE | ID: mdl-16941987

RESUMEN

The clinical and mechanism studies of acupuncture and moxibustion in treatment of dementia from modern literature in recent 15 years are reviewed. In clinical studies, changes of scores for relative dementia scale and daily life scale, relative laboratory indexes, imaging indexes and physical diagnostic indexes after acupuncture are explored. In studies of mechanisms, dementia models are established with different methods and changes of various indexes were observed. Studies find that acupuncture and moxibustion can improve intelligence and social activity ability, increase therapeutic effect and have good effects on important indexes of dementia. However, the criteria for diagnosis, therapeutic effects, syndrome standardization, evaluation of long-term therapeutic effects and prognosis for dementia still need to be further studied.


Asunto(s)
Enfermedad de Alzheimer , Moxibustión , Acupuntura , Puntos de Acupuntura , Terapia por Acupuntura , Humanos , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA